nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2D6—Alzheimer's disease	0.249	1	CbGaD
Ropivacaine—CYP2B6—Memantine—Alzheimer's disease	0.109	0.275	CbGbCtD
Ropivacaine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0762	0.192	CbGbCtD
Ropivacaine—CYP2D6—Donepezil—Alzheimer's disease	0.0609	0.153	CbGbCtD
Ropivacaine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0484	0.122	CbGbCtD
Ropivacaine—CYP2D6—Galantamine—Alzheimer's disease	0.0392	0.0987	CbGbCtD
Ropivacaine—CYP3A4—Donepezil—Alzheimer's disease	0.0387	0.0974	CbGbCtD
Ropivacaine—CYP3A4—Galantamine—Alzheimer's disease	0.025	0.0627	CbGbCtD
Ropivacaine—SCN8A—cerebellar cortex—Alzheimer's disease	0.0162	0.265	CbGeAlD
Ropivacaine—SCN8A—forebrain—Alzheimer's disease	0.00246	0.0403	CbGeAlD
Ropivacaine—SCN8A—telencephalon—Alzheimer's disease	0.00226	0.037	CbGeAlD
Ropivacaine—SCN1A—forebrain—Alzheimer's disease	0.00186	0.0304	CbGeAlD
Ropivacaine—SCN1A—telencephalon—Alzheimer's disease	0.00171	0.028	CbGeAlD
Ropivacaine—SCN2A—forebrain—Alzheimer's disease	0.00171	0.0279	CbGeAlD
Ropivacaine—SCN10A—forebrain—Alzheimer's disease	0.00165	0.0269	CbGeAlD
Ropivacaine—SCN2A—telencephalon—Alzheimer's disease	0.00157	0.0257	CbGeAlD
Ropivacaine—SCN10A—telencephalon—Alzheimer's disease	0.00151	0.0248	CbGeAlD
Ropivacaine—SCN3A—forebrain—Alzheimer's disease	0.0015	0.0245	CbGeAlD
Ropivacaine—SCN3A—telencephalon—Alzheimer's disease	0.00138	0.0226	CbGeAlD
Ropivacaine—SCN8A—nervous system—Alzheimer's disease	0.00134	0.0219	CbGeAlD
Ropivacaine—SCN8A—central nervous system—Alzheimer's disease	0.00129	0.021	CbGeAlD
Ropivacaine—SCN8A—cerebellum—Alzheimer's disease	0.00126	0.0206	CbGeAlD
Ropivacaine—SCN4A—nervous system—Alzheimer's disease	0.00105	0.0171	CbGeAlD
Ropivacaine—SCN8A—brain—Alzheimer's disease	0.00102	0.0167	CbGeAlD
Ropivacaine—SCN1A—nervous system—Alzheimer's disease	0.00101	0.0165	CbGeAlD
Ropivacaine—SCN4A—central nervous system—Alzheimer's disease	0.00101	0.0165	CbGeAlD
Ropivacaine—SCN1A—central nervous system—Alzheimer's disease	0.000972	0.0159	CbGeAlD
Ropivacaine—SCN1A—cerebellum—Alzheimer's disease	0.00095	0.0155	CbGeAlD
Ropivacaine—SCN2A—nervous system—Alzheimer's disease	0.000926	0.0152	CbGeAlD
Ropivacaine—SCN9A—brain—Alzheimer's disease	0.000897	0.0147	CbGeAlD
Ropivacaine—SCN10A—nervous system—Alzheimer's disease	0.000893	0.0146	CbGeAlD
Ropivacaine—SCN2A—central nervous system—Alzheimer's disease	0.000892	0.0146	CbGeAlD
Ropivacaine—SCN2A—cerebellum—Alzheimer's disease	0.000872	0.0143	CbGeAlD
Ropivacaine—SCN10A—central nervous system—Alzheimer's disease	0.00086	0.0141	CbGeAlD
Ropivacaine—SCN3A—nervous system—Alzheimer's disease	0.000814	0.0133	CbGeAlD
Ropivacaine—SCN5A—nervous system—Alzheimer's disease	0.000812	0.0133	CbGeAlD
Ropivacaine—SCN4A—brain—Alzheimer's disease	0.0008	0.0131	CbGeAlD
Ropivacaine—SCN3A—central nervous system—Alzheimer's disease	0.000784	0.0128	CbGeAlD
Ropivacaine—SCN5A—central nervous system—Alzheimer's disease	0.000782	0.0128	CbGeAlD
Ropivacaine—SCN1A—brain—Alzheimer's disease	0.000772	0.0126	CbGeAlD
Ropivacaine—SCN3A—cerebellum—Alzheimer's disease	0.000766	0.0125	CbGeAlD
Ropivacaine—SCN2A—brain—Alzheimer's disease	0.000708	0.0116	CbGeAlD
Ropivacaine—SCN10A—brain—Alzheimer's disease	0.000683	0.0112	CbGeAlD
Ropivacaine—SCN3A—brain—Alzheimer's disease	0.000622	0.0102	CbGeAlD
Ropivacaine—SCN5A—brain—Alzheimer's disease	0.000621	0.0102	CbGeAlD
Ropivacaine—CYP2D6—forebrain—Alzheimer's disease	0.000561	0.00918	CbGeAlD
Ropivacaine—CYP2D6—telencephalon—Alzheimer's disease	0.000516	0.00844	CbGeAlD
Ropivacaine—Ranolazine—CYP2D6—Alzheimer's disease	0.000491	0.391	CrCbGaD
Ropivacaine—Bupivacaine—CYP2D6—Alzheimer's disease	0.000481	0.384	CrCbGaD
Ropivacaine—Dysuria—Memantine—Alzheimer's disease	0.000426	0.00194	CcSEcCtD
Ropivacaine—Vision blurred—Galantamine—Alzheimer's disease	0.000425	0.00194	CcSEcCtD
Ropivacaine—Tremor—Galantamine—Alzheimer's disease	0.000422	0.00193	CcSEcCtD
Ropivacaine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000418	0.00191	CcSEcCtD
Ropivacaine—Anaemia—Galantamine—Alzheimer's disease	0.000417	0.0019	CcSEcCtD
Ropivacaine—Dysuria—Rivastigmine—Alzheimer's disease	0.000416	0.0019	CcSEcCtD
Ropivacaine—Agitation—Galantamine—Alzheimer's disease	0.000414	0.00189	CcSEcCtD
Ropivacaine—Hyperglycaemia—Memantine—Alzheimer's disease	0.000411	0.00187	CcSEcCtD
Ropivacaine—CYP2B6—nervous system—Alzheimer's disease	0.00041	0.00671	CbGeAlD
Ropivacaine—Bradycardia—Donepezil—Alzheimer's disease	0.000409	0.00186	CcSEcCtD
Ropivacaine—Malaise—Galantamine—Alzheimer's disease	0.000407	0.00185	CcSEcCtD
Ropivacaine—Vertigo—Galantamine—Alzheimer's disease	0.000405	0.00185	CcSEcCtD
Ropivacaine—Depression—Memantine—Alzheimer's disease	0.000405	0.00185	CcSEcCtD
Ropivacaine—Syncope—Galantamine—Alzheimer's disease	0.000404	0.00184	CcSEcCtD
Ropivacaine—Rhinitis—Donepezil—Alzheimer's disease	0.000402	0.00183	CcSEcCtD
Ropivacaine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000402	0.00183	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.0004	0.00182	CcSEcCtD
Ropivacaine—Hallucination—Donepezil—Alzheimer's disease	0.000399	0.00182	CcSEcCtD
Ropivacaine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000399	0.00182	CcSEcCtD
Ropivacaine—Myocardial infarction—Memantine—Alzheimer's disease	0.000398	0.00181	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000398	0.00181	CcSEcCtD
Ropivacaine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000397	0.00181	CcSEcCtD
Ropivacaine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000396	0.00181	CcSEcCtD
Ropivacaine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000396	0.00181	CcSEcCtD
Ropivacaine—Depression—Rivastigmine—Alzheimer's disease	0.000396	0.00181	CcSEcCtD
Ropivacaine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000395	0.0018	CcSEcCtD
Ropivacaine—Urinary tract infection—Memantine—Alzheimer's disease	0.000395	0.0018	CcSEcCtD
Ropivacaine—CYP2B6—central nervous system—Alzheimer's disease	0.000394	0.00646	CbGeAlD
Ropivacaine—Urethral disorder—Donepezil—Alzheimer's disease	0.000393	0.00179	CcSEcCtD
Ropivacaine—Cough—Galantamine—Alzheimer's disease	0.000393	0.00179	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000391	0.00179	CcSEcCtD
Ropivacaine—Convulsion—Galantamine—Alzheimer's disease	0.000391	0.00178	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000389	0.00178	CcSEcCtD
Ropivacaine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000389	0.00178	CcSEcCtD
Ropivacaine—Hypertension—Galantamine—Alzheimer's disease	0.000389	0.00177	CcSEcCtD
Ropivacaine—Haematuria—Memantine—Alzheimer's disease	0.000387	0.00176	CcSEcCtD
Ropivacaine—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000386	0.00176	CcSEcCtD
Ropivacaine—Arthralgia—Galantamine—Alzheimer's disease	0.000384	0.00175	CcSEcCtD
Ropivacaine—Chest pain—Galantamine—Alzheimer's disease	0.000384	0.00175	CcSEcCtD
Ropivacaine—Myalgia—Galantamine—Alzheimer's disease	0.000384	0.00175	CcSEcCtD
Ropivacaine—Anxiety—Galantamine—Alzheimer's disease	0.000382	0.00174	CcSEcCtD
Ropivacaine—Discomfort—Galantamine—Alzheimer's disease	0.000379	0.00173	CcSEcCtD
Ropivacaine—Haematuria—Rivastigmine—Alzheimer's disease	0.000379	0.00173	CcSEcCtD
Ropivacaine—Tinnitus—Donepezil—Alzheimer's disease	0.000374	0.00171	CcSEcCtD
Ropivacaine—Confusional state—Galantamine—Alzheimer's disease	0.000371	0.00169	CcSEcCtD
Ropivacaine—Bradycardia—Memantine—Alzheimer's disease	0.000371	0.00169	CcSEcCtD
Ropivacaine—Rhinitis—Memantine—Alzheimer's disease	0.000365	0.00167	CcSEcCtD
Ropivacaine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000363	0.00165	CcSEcCtD
Ropivacaine—Hallucination—Memantine—Alzheimer's disease	0.000363	0.00165	CcSEcCtD
Ropivacaine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000363	0.00165	CcSEcCtD
Ropivacaine—Shock—Galantamine—Alzheimer's disease	0.000362	0.00165	CcSEcCtD
Ropivacaine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00036	0.00164	CcSEcCtD
Ropivacaine—Chills—Donepezil—Alzheimer's disease	0.00036	0.00164	CcSEcCtD
Ropivacaine—Urinary tract disorder—Memantine—Alzheimer's disease	0.00036	0.00164	CcSEcCtD
Ropivacaine—Tachycardia—Galantamine—Alzheimer's disease	0.000359	0.00164	CcSEcCtD
Ropivacaine—Oedema peripheral—Memantine—Alzheimer's disease	0.000359	0.00164	CcSEcCtD
Ropivacaine—Arrhythmia—Donepezil—Alzheimer's disease	0.000359	0.00163	CcSEcCtD
Ropivacaine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000357	0.00163	CcSEcCtD
Ropivacaine—Skin disorder—Galantamine—Alzheimer's disease	0.000357	0.00163	CcSEcCtD
Ropivacaine—Urethral disorder—Memantine—Alzheimer's disease	0.000357	0.00163	CcSEcCtD
Ropivacaine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000356	0.00162	CcSEcCtD
Ropivacaine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000355	0.00162	CcSEcCtD
Ropivacaine—Hallucination—Rivastigmine—Alzheimer's disease	0.000355	0.00162	CcSEcCtD
Ropivacaine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000352	0.00161	CcSEcCtD
Ropivacaine—Mental disorder—Donepezil—Alzheimer's disease	0.000352	0.0016	CcSEcCtD
Ropivacaine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000351	0.0016	CcSEcCtD
Ropivacaine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000349	0.00159	CcSEcCtD
Ropivacaine—Erythema—Donepezil—Alzheimer's disease	0.000349	0.00159	CcSEcCtD
Ropivacaine—Hypotension—Galantamine—Alzheimer's disease	0.000344	0.00157	CcSEcCtD
Ropivacaine—Tension—Donepezil—Alzheimer's disease	0.000343	0.00156	CcSEcCtD
Ropivacaine—Tinnitus—Memantine—Alzheimer's disease	0.00034	0.00155	CcSEcCtD
Ropivacaine—Nervousness—Donepezil—Alzheimer's disease	0.000339	0.00155	CcSEcCtD
Ropivacaine—Cardiac disorder—Memantine—Alzheimer's disease	0.000338	0.00154	CcSEcCtD
Ropivacaine—Back pain—Donepezil—Alzheimer's disease	0.000338	0.00154	CcSEcCtD
Ropivacaine—Muscle spasms—Donepezil—Alzheimer's disease	0.000336	0.00153	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000335	0.00153	CcSEcCtD
Ropivacaine—Insomnia—Galantamine—Alzheimer's disease	0.000333	0.00152	CcSEcCtD
Ropivacaine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000332	0.00152	CcSEcCtD
Ropivacaine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000331	0.00151	CcSEcCtD
Ropivacaine—Paraesthesia—Galantamine—Alzheimer's disease	0.00033	0.00151	CcSEcCtD
Ropivacaine—Vision blurred—Donepezil—Alzheimer's disease	0.000329	0.0015	CcSEcCtD
Ropivacaine—Tremor—Donepezil—Alzheimer's disease	0.000327	0.00149	CcSEcCtD
Ropivacaine—Somnolence—Galantamine—Alzheimer's disease	0.000327	0.00149	CcSEcCtD
Ropivacaine—Chills—Memantine—Alzheimer's disease	0.000327	0.00149	CcSEcCtD
Ropivacaine—Arrhythmia—Memantine—Alzheimer's disease	0.000326	0.00148	CcSEcCtD
Ropivacaine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000324	0.00148	CcSEcCtD
Ropivacaine—Dyspepsia—Galantamine—Alzheimer's disease	0.000324	0.00148	CcSEcCtD
Ropivacaine—Anaemia—Donepezil—Alzheimer's disease	0.000323	0.00147	CcSEcCtD
Ropivacaine—Agitation—Donepezil—Alzheimer's disease	0.000321	0.00146	CcSEcCtD
Ropivacaine—Chills—Rivastigmine—Alzheimer's disease	0.00032	0.00146	CcSEcCtD
Ropivacaine—Mental disorder—Memantine—Alzheimer's disease	0.000319	0.00146	CcSEcCtD
Ropivacaine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000318	0.00145	CcSEcCtD
Ropivacaine—Malaise—Donepezil—Alzheimer's disease	0.000315	0.00144	CcSEcCtD
Ropivacaine—Constipation—Galantamine—Alzheimer's disease	0.000315	0.00143	CcSEcCtD
Ropivacaine—Vertigo—Donepezil—Alzheimer's disease	0.000314	0.00143	CcSEcCtD
Ropivacaine—Syncope—Donepezil—Alzheimer's disease	0.000313	0.00143	CcSEcCtD
Ropivacaine—CYP2B6—brain—Alzheimer's disease	0.000313	0.00513	CbGeAlD
Ropivacaine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000312	0.00142	CcSEcCtD
Ropivacaine—Tension—Memantine—Alzheimer's disease	0.000311	0.00142	CcSEcCtD
Ropivacaine—Erythema—Rivastigmine—Alzheimer's disease	0.00031	0.00142	CcSEcCtD
Ropivacaine—CYP3A4—nervous system—Alzheimer's disease	0.000309	0.00506	CbGeAlD
Ropivacaine—Nervousness—Memantine—Alzheimer's disease	0.000308	0.00141	CcSEcCtD
Ropivacaine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000307	0.0014	CcSEcCtD
Ropivacaine—Back pain—Memantine—Alzheimer's disease	0.000307	0.0014	CcSEcCtD
Ropivacaine—Cough—Donepezil—Alzheimer's disease	0.000305	0.00139	CcSEcCtD
Ropivacaine—Tension—Rivastigmine—Alzheimer's disease	0.000305	0.00139	CcSEcCtD
Ropivacaine—CYP2D6—nervous system—Alzheimer's disease	0.000304	0.00498	CbGeAlD
Ropivacaine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000303	0.00138	CcSEcCtD
Ropivacaine—Convulsion—Donepezil—Alzheimer's disease	0.000303	0.00138	CcSEcCtD
Ropivacaine—Hypertension—Donepezil—Alzheimer's disease	0.000302	0.00138	CcSEcCtD
Ropivacaine—Nervousness—Rivastigmine—Alzheimer's disease	0.000301	0.00137	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000301	0.00137	CcSEcCtD
Ropivacaine—Back pain—Rivastigmine—Alzheimer's disease	0.0003	0.00137	CcSEcCtD
Ropivacaine—Vision blurred—Memantine—Alzheimer's disease	0.000299	0.00136	CcSEcCtD
Ropivacaine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000298	0.00136	CcSEcCtD
Ropivacaine—CYP3A4—central nervous system—Alzheimer's disease	0.000298	0.00487	CbGeAlD
Ropivacaine—Myalgia—Donepezil—Alzheimer's disease	0.000297	0.00136	CcSEcCtD
Ropivacaine—Chest pain—Donepezil—Alzheimer's disease	0.000297	0.00136	CcSEcCtD
Ropivacaine—Arthralgia—Donepezil—Alzheimer's disease	0.000297	0.00136	CcSEcCtD
Ropivacaine—Tremor—Memantine—Alzheimer's disease	0.000297	0.00136	CcSEcCtD
Ropivacaine—Anxiety—Donepezil—Alzheimer's disease	0.000296	0.00135	CcSEcCtD
Ropivacaine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000294	0.00134	CcSEcCtD
Ropivacaine—Discomfort—Donepezil—Alzheimer's disease	0.000294	0.00134	CcSEcCtD
Ropivacaine—Anaemia—Memantine—Alzheimer's disease	0.000293	0.00134	CcSEcCtD
Ropivacaine—CYP2D6—central nervous system—Alzheimer's disease	0.000293	0.0048	CbGeAlD
Ropivacaine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000292	0.00133	CcSEcCtD
Ropivacaine—Agitation—Memantine—Alzheimer's disease	0.000292	0.00133	CcSEcCtD
Ropivacaine—Abdominal pain—Galantamine—Alzheimer's disease	0.000291	0.00133	CcSEcCtD
Ropivacaine—Body temperature increased—Galantamine—Alzheimer's disease	0.000291	0.00133	CcSEcCtD
Ropivacaine—Tremor—Rivastigmine—Alzheimer's disease	0.000291	0.00133	CcSEcCtD
Ropivacaine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000288	0.00131	CcSEcCtD
Ropivacaine—Confusional state—Donepezil—Alzheimer's disease	0.000288	0.00131	CcSEcCtD
Ropivacaine—Anaemia—Rivastigmine—Alzheimer's disease	0.000287	0.00131	CcSEcCtD
Ropivacaine—CYP2D6—cerebellum—Alzheimer's disease	0.000286	0.00469	CbGeAlD
Ropivacaine—Malaise—Memantine—Alzheimer's disease	0.000286	0.0013	CcSEcCtD
Ropivacaine—Agitation—Rivastigmine—Alzheimer's disease	0.000285	0.0013	CcSEcCtD
Ropivacaine—Vertigo—Memantine—Alzheimer's disease	0.000285	0.0013	CcSEcCtD
Ropivacaine—Syncope—Memantine—Alzheimer's disease	0.000284	0.0013	CcSEcCtD
Ropivacaine—Infection—Donepezil—Alzheimer's disease	0.000283	0.00129	CcSEcCtD
Ropivacaine—Lidocaine—CYP2D6—Alzheimer's disease	0.000282	0.225	CrCbGaD
Ropivacaine—Shock—Donepezil—Alzheimer's disease	0.000281	0.00128	CcSEcCtD
Ropivacaine—Malaise—Rivastigmine—Alzheimer's disease	0.00028	0.00128	CcSEcCtD
Ropivacaine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000279	0.00127	CcSEcCtD
Ropivacaine—Vertigo—Rivastigmine—Alzheimer's disease	0.000279	0.00127	CcSEcCtD
Ropivacaine—Loss of consciousness—Memantine—Alzheimer's disease	0.000279	0.00127	CcSEcCtD
Ropivacaine—Syncope—Rivastigmine—Alzheimer's disease	0.000278	0.00127	CcSEcCtD
Ropivacaine—Cough—Memantine—Alzheimer's disease	0.000277	0.00126	CcSEcCtD
Ropivacaine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000276	0.00126	CcSEcCtD
Ropivacaine—Convulsion—Memantine—Alzheimer's disease	0.000275	0.00125	CcSEcCtD
Ropivacaine—Hypertension—Memantine—Alzheimer's disease	0.000274	0.00125	CcSEcCtD
Ropivacaine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000273	0.00124	CcSEcCtD
Ropivacaine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000271	0.00124	CcSEcCtD
Ropivacaine—Cough—Rivastigmine—Alzheimer's disease	0.000271	0.00123	CcSEcCtD
Ropivacaine—Myalgia—Memantine—Alzheimer's disease	0.00027	0.00123	CcSEcCtD
Ropivacaine—Chest pain—Memantine—Alzheimer's disease	0.00027	0.00123	CcSEcCtD
Ropivacaine—Arthralgia—Memantine—Alzheimer's disease	0.00027	0.00123	CcSEcCtD
Ropivacaine—Anxiety—Memantine—Alzheimer's disease	0.000269	0.00123	CcSEcCtD
Ropivacaine—Convulsion—Rivastigmine—Alzheimer's disease	0.000269	0.00123	CcSEcCtD
Ropivacaine—Hypertension—Rivastigmine—Alzheimer's disease	0.000268	0.00122	CcSEcCtD
Ropivacaine—Discomfort—Memantine—Alzheimer's disease	0.000267	0.00122	CcSEcCtD
Ropivacaine—Hypotension—Donepezil—Alzheimer's disease	0.000266	0.00122	CcSEcCtD
Ropivacaine—Chest pain—Rivastigmine—Alzheimer's disease	0.000264	0.0012	CcSEcCtD
Ropivacaine—Myalgia—Rivastigmine—Alzheimer's disease	0.000264	0.0012	CcSEcCtD
Ropivacaine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000264	0.0012	CcSEcCtD
Ropivacaine—Asthenia—Galantamine—Alzheimer's disease	0.000264	0.0012	CcSEcCtD
Ropivacaine—Anxiety—Rivastigmine—Alzheimer's disease	0.000263	0.0012	CcSEcCtD
Ropivacaine—Confusional state—Memantine—Alzheimer's disease	0.000261	0.00119	CcSEcCtD
Ropivacaine—Discomfort—Rivastigmine—Alzheimer's disease	0.000261	0.00119	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00026	0.00118	CcSEcCtD
Ropivacaine—Insomnia—Donepezil—Alzheimer's disease	0.000258	0.00118	CcSEcCtD
Ropivacaine—Infection—Memantine—Alzheimer's disease	0.000257	0.00117	CcSEcCtD
Ropivacaine—Paraesthesia—Donepezil—Alzheimer's disease	0.000256	0.00117	CcSEcCtD
Ropivacaine—Confusional state—Rivastigmine—Alzheimer's disease	0.000255	0.00116	CcSEcCtD
Ropivacaine—Shock—Memantine—Alzheimer's disease	0.000255	0.00116	CcSEcCtD
Ropivacaine—Dyspnoea—Donepezil—Alzheimer's disease	0.000254	0.00116	CcSEcCtD
Ropivacaine—Somnolence—Donepezil—Alzheimer's disease	0.000253	0.00116	CcSEcCtD
Ropivacaine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000253	0.00116	CcSEcCtD
Ropivacaine—Tachycardia—Memantine—Alzheimer's disease	0.000253	0.00115	CcSEcCtD
Ropivacaine—Diarrhoea—Galantamine—Alzheimer's disease	0.000252	0.00115	CcSEcCtD
Ropivacaine—Infection—Rivastigmine—Alzheimer's disease	0.000252	0.00115	CcSEcCtD
Ropivacaine—Skin disorder—Memantine—Alzheimer's disease	0.000251	0.00115	CcSEcCtD
Ropivacaine—Dyspepsia—Donepezil—Alzheimer's disease	0.000251	0.00114	CcSEcCtD
Ropivacaine—Hyperhidrosis—Memantine—Alzheimer's disease	0.00025	0.00114	CcSEcCtD
Ropivacaine—Shock—Rivastigmine—Alzheimer's disease	0.000249	0.00114	CcSEcCtD
Ropivacaine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000248	0.00113	CcSEcCtD
Ropivacaine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000247	0.00113	CcSEcCtD
Ropivacaine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000246	0.00112	CcSEcCtD
Ropivacaine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000245	0.00112	CcSEcCtD
Ropivacaine—Pain—Donepezil—Alzheimer's disease	0.000244	0.00111	CcSEcCtD
Ropivacaine—Constipation—Donepezil—Alzheimer's disease	0.000244	0.00111	CcSEcCtD
Ropivacaine—Dizziness—Galantamine—Alzheimer's disease	0.000243	0.00111	CcSEcCtD
Ropivacaine—Hypotension—Memantine—Alzheimer's disease	0.000242	0.0011	CcSEcCtD
Ropivacaine—Hypotension—Rivastigmine—Alzheimer's disease	0.000237	0.00108	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000236	0.00108	CcSEcCtD
Ropivacaine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000235	0.00107	CcSEcCtD
Ropivacaine—Insomnia—Memantine—Alzheimer's disease	0.000234	0.00107	CcSEcCtD
Ropivacaine—Vomiting—Galantamine—Alzheimer's disease	0.000234	0.00107	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000233	0.00106	CcSEcCtD
Ropivacaine—CYP2D6—brain—Alzheimer's disease	0.000233	0.00381	CbGeAlD
Ropivacaine—Paraesthesia—Memantine—Alzheimer's disease	0.000232	0.00106	CcSEcCtD
Ropivacaine—Rash—Galantamine—Alzheimer's disease	0.000232	0.00106	CcSEcCtD
Ropivacaine—Dermatitis—Galantamine—Alzheimer's disease	0.000232	0.00106	CcSEcCtD
Ropivacaine—Dyspnoea—Memantine—Alzheimer's disease	0.000231	0.00105	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000231	0.00105	CcSEcCtD
Ropivacaine—Headache—Galantamine—Alzheimer's disease	0.00023	0.00105	CcSEcCtD
Ropivacaine—Somnolence—Memantine—Alzheimer's disease	0.00023	0.00105	CcSEcCtD
Ropivacaine—Insomnia—Rivastigmine—Alzheimer's disease	0.000229	0.00104	CcSEcCtD
Ropivacaine—Dyspepsia—Memantine—Alzheimer's disease	0.000228	0.00104	CcSEcCtD
Ropivacaine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000227	0.00104	CcSEcCtD
Ropivacaine—Urticaria—Donepezil—Alzheimer's disease	0.000227	0.00103	CcSEcCtD
Ropivacaine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000226	0.00103	CcSEcCtD
Ropivacaine—Abdominal pain—Donepezil—Alzheimer's disease	0.000225	0.00103	CcSEcCtD
Ropivacaine—Body temperature increased—Donepezil—Alzheimer's disease	0.000225	0.00103	CcSEcCtD
Ropivacaine—Somnolence—Rivastigmine—Alzheimer's disease	0.000225	0.00103	CcSEcCtD
Ropivacaine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000223	0.00102	CcSEcCtD
Ropivacaine—Constipation—Memantine—Alzheimer's disease	0.000221	0.00101	CcSEcCtD
Ropivacaine—Pain—Memantine—Alzheimer's disease	0.000221	0.00101	CcSEcCtD
Ropivacaine—Nausea—Galantamine—Alzheimer's disease	0.000219	0.000997	CcSEcCtD
Ropivacaine—Constipation—Rivastigmine—Alzheimer's disease	0.000217	0.000988	CcSEcCtD
Ropivacaine—Pain—Rivastigmine—Alzheimer's disease	0.000217	0.000988	CcSEcCtD
Ropivacaine—Feeling abnormal—Memantine—Alzheimer's disease	0.000213	0.000973	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000212	0.000965	CcSEcCtD
Ropivacaine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00021	0.000958	CcSEcCtD
Ropivacaine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000209	0.000952	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000207	0.000944	CcSEcCtD
Ropivacaine—Urticaria—Memantine—Alzheimer's disease	0.000206	0.000938	CcSEcCtD
Ropivacaine—Abdominal pain—Memantine—Alzheimer's disease	0.000205	0.000933	CcSEcCtD
Ropivacaine—Body temperature increased—Memantine—Alzheimer's disease	0.000205	0.000933	CcSEcCtD
Ropivacaine—Asthenia—Donepezil—Alzheimer's disease	0.000205	0.000933	CcSEcCtD
Ropivacaine—Pruritus—Donepezil—Alzheimer's disease	0.000202	0.00092	CcSEcCtD
Ropivacaine—Urticaria—Rivastigmine—Alzheimer's disease	0.000201	0.000918	CcSEcCtD
Ropivacaine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.0002	0.000913	CcSEcCtD
Ropivacaine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.0002	0.000913	CcSEcCtD
Ropivacaine—Diarrhoea—Donepezil—Alzheimer's disease	0.000195	0.00089	CcSEcCtD
Ropivacaine—Hypersensitivity—Memantine—Alzheimer's disease	0.000191	0.00087	CcSEcCtD
Ropivacaine—Dizziness—Donepezil—Alzheimer's disease	0.000189	0.00086	CcSEcCtD
Ropivacaine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000187	0.000851	CcSEcCtD
Ropivacaine—Asthenia—Memantine—Alzheimer's disease	0.000186	0.000847	CcSEcCtD
Ropivacaine—Pruritus—Memantine—Alzheimer's disease	0.000183	0.000835	CcSEcCtD
Ropivacaine—Asthenia—Rivastigmine—Alzheimer's disease	0.000182	0.000829	CcSEcCtD
Ropivacaine—Vomiting—Donepezil—Alzheimer's disease	0.000181	0.000827	CcSEcCtD
Ropivacaine—Rash—Donepezil—Alzheimer's disease	0.00018	0.00082	CcSEcCtD
Ropivacaine—Dermatitis—Donepezil—Alzheimer's disease	0.00018	0.000819	CcSEcCtD
Ropivacaine—Pruritus—Rivastigmine—Alzheimer's disease	0.000179	0.000817	CcSEcCtD
Ropivacaine—Headache—Donepezil—Alzheimer's disease	0.000179	0.000815	CcSEcCtD
Ropivacaine—Diarrhoea—Memantine—Alzheimer's disease	0.000177	0.000808	CcSEcCtD
Ropivacaine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000173	0.00079	CcSEcCtD
Ropivacaine—Dizziness—Memantine—Alzheimer's disease	0.000171	0.000781	CcSEcCtD
Ropivacaine—Nausea—Donepezil—Alzheimer's disease	0.000169	0.000772	CcSEcCtD
Ropivacaine—Dizziness—Rivastigmine—Alzheimer's disease	0.000167	0.000764	CcSEcCtD
Ropivacaine—Vomiting—Memantine—Alzheimer's disease	0.000165	0.000751	CcSEcCtD
Ropivacaine—Rash—Memantine—Alzheimer's disease	0.000163	0.000744	CcSEcCtD
Ropivacaine—Dermatitis—Memantine—Alzheimer's disease	0.000163	0.000744	CcSEcCtD
Ropivacaine—Headache—Memantine—Alzheimer's disease	0.000162	0.00074	CcSEcCtD
Ropivacaine—Vomiting—Rivastigmine—Alzheimer's disease	0.000161	0.000734	CcSEcCtD
Ropivacaine—Rash—Rivastigmine—Alzheimer's disease	0.00016	0.000728	CcSEcCtD
Ropivacaine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00016	0.000728	CcSEcCtD
Ropivacaine—Headache—Rivastigmine—Alzheimer's disease	0.000159	0.000724	CcSEcCtD
Ropivacaine—Nausea—Memantine—Alzheimer's disease	0.000154	0.000701	CcSEcCtD
Ropivacaine—Nausea—Rivastigmine—Alzheimer's disease	0.00015	0.000686	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—GSK3B—Alzheimer's disease	4.9e-05	0.000688	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CREB1—Alzheimer's disease	4.86e-05	0.000683	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NOTCH1—Alzheimer's disease	4.83e-05	0.00068	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NOTCH1—Alzheimer's disease	4.83e-05	0.00068	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—INS—Alzheimer's disease	4.83e-05	0.000679	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PPARGC1A—Alzheimer's disease	4.83e-05	0.000678	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	4.77e-05	0.000671	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—PPARG—Alzheimer's disease	4.73e-05	0.000665	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—PPARG—Alzheimer's disease	4.73e-05	0.000665	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—GSK3B—Alzheimer's disease	4.7e-05	0.000661	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—GSK3B—Alzheimer's disease	4.7e-05	0.000661	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CREB1—Alzheimer's disease	4.67e-05	0.000656	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CREB1—Alzheimer's disease	4.67e-05	0.000656	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—INS—Alzheimer's disease	4.64e-05	0.000653	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—INS—Alzheimer's disease	4.64e-05	0.000653	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—PPARG—Alzheimer's disease	4.56e-05	0.000642	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—PPARG—Alzheimer's disease	4.56e-05	0.000642	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—GSK3B—Alzheimer's disease	4.54e-05	0.000638	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—GSK3B—Alzheimer's disease	4.54e-05	0.000638	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CREB1—Alzheimer's disease	4.5e-05	0.000633	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CREB1—Alzheimer's disease	4.5e-05	0.000633	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—INS—Alzheimer's disease	4.48e-05	0.000629	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—INS—Alzheimer's disease	4.48e-05	0.000629	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—VEGFA—Alzheimer's disease	4.47e-05	0.000629	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—GSK3B—Alzheimer's disease	4.47e-05	0.000628	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	4.45e-05	0.000625	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—CREB1—Alzheimer's disease	4.43e-05	0.000623	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—LPL—Alzheimer's disease	4.39e-05	0.000618	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MEF2C—Alzheimer's disease	4.35e-05	0.000612	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	4.28e-05	0.000602	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—VEGFA—Alzheimer's disease	4.28e-05	0.000601	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	4.16e-05	0.000585	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	4.14e-05	0.000582	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	4.11e-05	0.000578	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—VEGFA—Alzheimer's disease	4.11e-05	0.000578	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—VEGFA—Alzheimer's disease	4.11e-05	0.000578	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	4.04e-05	0.000568	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	3.96e-05	0.000557	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—VEGFA—Alzheimer's disease	3.96e-05	0.000557	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—VEGFA—Alzheimer's disease	3.96e-05	0.000557	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—VEGFA—Alzheimer's disease	3.95e-05	0.000555	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.91e-05	0.000549	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—DHCR24—Alzheimer's disease	3.89e-05	0.000547	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—IL6—Alzheimer's disease	3.82e-05	0.000538	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	3.72e-05	0.000523	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—LEP—Alzheimer's disease	3.68e-05	0.000518	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TGFB1—Alzheimer's disease	3.62e-05	0.000509	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	3.5e-05	0.000493	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.46e-05	0.000486	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.43e-05	0.000482	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NOTCH1—Alzheimer's disease	3.4e-05	0.000478	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TNF—Alzheimer's disease	3.38e-05	0.000475	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CA4—Alzheimer's disease	3.31e-05	0.000465	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	3.22e-05	0.000452	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PPARG—Alzheimer's disease	3.21e-05	0.000451	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—Alzheimer's disease	3.19e-05	0.000449	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—GSK3B—Alzheimer's disease	3.19e-05	0.000448	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CREB1—Alzheimer's disease	3.16e-05	0.000445	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—INS—Alzheimer's disease	3.15e-05	0.000442	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	3.12e-05	0.000438	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GAPDHS—Alzheimer's disease	3.11e-05	0.000437	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6—Alzheimer's disease	3.09e-05	0.000435	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	3.06e-05	0.00043	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—Alzheimer's disease	3.05e-05	0.000429	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.02e-05	0.000424	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	3e-05	0.000422	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	3e-05	0.000422	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6—Alzheimer's disease	2.96e-05	0.000416	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ATP5A1—Alzheimer's disease	2.95e-05	0.000414	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—Alzheimer's disease	2.93e-05	0.000412	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—Alzheimer's disease	2.93e-05	0.000412	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TGFB1—Alzheimer's disease	2.93e-05	0.000412	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—Alzheimer's disease	2.84e-05	0.0004	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—Alzheimer's disease	2.84e-05	0.0004	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—Alzheimer's disease	2.83e-05	0.000398	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—Alzheimer's disease	2.83e-05	0.000398	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLD3—Alzheimer's disease	2.81e-05	0.000395	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TGFB1—Alzheimer's disease	2.8e-05	0.000394	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—Alzheimer's disease	2.79e-05	0.000392	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—Alzheimer's disease	2.74e-05	0.000385	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—Alzheimer's disease	2.74e-05	0.000385	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—Alzheimer's disease	2.73e-05	0.000384	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—Alzheimer's disease	2.73e-05	0.000384	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.7e-05	0.00038	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HSD17B10—Alzheimer's disease	2.7e-05	0.000379	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TGFB1—Alzheimer's disease	2.69e-05	0.000378	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TGFB1—Alzheimer's disease	2.69e-05	0.000378	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—Alzheimer's disease	2.62e-05	0.000368	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP46A1—Alzheimer's disease	2.6e-05	0.000365	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TGFB1—Alzheimer's disease	2.6e-05	0.000365	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TGFB1—Alzheimer's disease	2.6e-05	0.000365	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—AKT1—Alzheimer's disease	2.52e-05	0.000354	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—Alzheimer's disease	2.51e-05	0.000353	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—Alzheimer's disease	2.51e-05	0.000353	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ND1—Alzheimer's disease	2.51e-05	0.000352	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—Alzheimer's disease	2.42e-05	0.000341	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—Alzheimer's disease	2.42e-05	0.000341	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.3e-05	0.000323	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	2.29e-05	0.000322	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—Alzheimer's disease	2.21e-05	0.00031	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	2.16e-05	0.000304	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.14e-05	0.0003	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—Alzheimer's disease	2.11e-05	0.000297	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	2.05e-05	0.000288	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT1—Alzheimer's disease	2.04e-05	0.000286	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—Alzheimer's disease	2.03e-05	0.000285	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—Alzheimer's disease	2.03e-05	0.000285	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—Alzheimer's disease	1.99e-05	0.000279	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—Alzheimer's disease	1.96e-05	0.000275	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—Alzheimer's disease	1.96e-05	0.000275	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.95e-05	0.000275	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—Alzheimer's disease	1.95e-05	0.000274	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CA4—Alzheimer's disease	1.95e-05	0.000274	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—Alzheimer's disease	1.93e-05	0.000271	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.9e-05	0.000268	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.87e-05	0.000263	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—Alzheimer's disease	1.87e-05	0.000263	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—Alzheimer's disease	1.87e-05	0.000263	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	1.83e-05	0.000257	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TGFB1—Alzheimer's disease	1.82e-05	0.000257	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—Alzheimer's disease	1.8e-05	0.000254	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—Alzheimer's disease	1.8e-05	0.000254	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.8e-05	0.000254	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.77e-05	0.000248	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.74e-05	0.000245	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	1.74e-05	0.000244	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—Alzheimer's disease	1.7e-05	0.00024	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLD3—Alzheimer's disease	1.66e-05	0.000233	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.66e-05	0.000233	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.64e-05	0.00023	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CHAT—Alzheimer's disease	1.62e-05	0.000227	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TPI1—Alzheimer's disease	1.62e-05	0.000227	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.59e-05	0.000223	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.55e-05	0.000218	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MAOB—Alzheimer's disease	1.55e-05	0.000218	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.53e-05	0.000215	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.5e-05	0.000211	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GAPDH—Alzheimer's disease	1.49e-05	0.00021	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.48e-05	0.000207	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.44e-05	0.000203	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—A2M—Alzheimer's disease	1.44e-05	0.000202	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.41e-05	0.000199	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—Alzheimer's disease	1.37e-05	0.000193	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.34e-05	0.000188	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.32e-05	0.000185	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.28e-05	0.00018	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—Alzheimer's disease	1.27e-05	0.000178	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ACHE—Alzheimer's disease	1.25e-05	0.000176	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—INPP5D—Alzheimer's disease	1.24e-05	0.000174	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.23e-05	0.000172	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.18e-05	0.000166	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO1—Alzheimer's disease	1.17e-05	0.000165	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	1.17e-05	0.000165	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	1.15e-05	0.000162	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.14e-05	0.00016	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.14e-05	0.00016	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.12e-05	0.000158	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.12e-05	0.000158	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BCHE—Alzheimer's disease	1.09e-05	0.000153	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.08e-05	0.000151	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.04e-05	0.000146	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.04e-05	0.000146	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	1.03e-05	0.000145	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—A2M—Alzheimer's disease	1e-05	0.000141	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	9.98e-06	0.00014	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	9.51e-06	0.000134	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TPI1—Alzheimer's disease	9.51e-06	0.000134	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	9.12e-06	0.000128	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	8.78e-06	0.000123	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.7e-06	0.000122	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.68e-06	0.000122	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.6e-06	0.000121	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	8.6e-06	0.000121	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.6e-06	0.000121	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	8.56e-06	0.00012	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—A2M—Alzheimer's disease	8.48e-06	0.000119	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	8.16e-06	0.000115	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	8.16e-06	0.000115	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LPL—Alzheimer's disease	7.83e-06	0.00011	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.58e-06	0.000107	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.56e-06	0.000106	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	7.37e-06	0.000104	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.34e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.34e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	7.29e-06	0.000102	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	7.15e-06	0.000101	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	7.05e-06	9.91e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.04e-06	9.89e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.94e-06	9.75e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	6.91e-06	9.71e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	6.91e-06	9.71e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	6.78e-06	9.53e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.77e-06	9.52e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CALM1—Alzheimer's disease	6.59e-06	9.26e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOE—Alzheimer's disease	6.56e-06	9.23e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—A2M—Alzheimer's disease	6.54e-06	9.2e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CAV1—Alzheimer's disease	6.5e-06	9.14e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	6.42e-06	9.03e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	6.06e-06	8.52e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.98e-06	8.4e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.95e-06	8.37e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.95e-06	8.36e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	5.88e-06	8.26e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	5.72e-06	8.04e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.69e-06	8e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.63e-06	7.91e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—INS—Alzheimer's disease	5.61e-06	7.88e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.44e-06	7.65e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.33e-06	7.5e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.33e-06	7.5e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.23e-06	7.35e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	5.06e-06	7.12e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	5.04e-06	7.09e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.96e-06	6.97e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	4.92e-06	6.91e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.9e-06	6.89e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.68e-06	6.58e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.61e-06	6.48e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.58e-06	6.44e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.56e-06	6.41e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.53e-06	6.37e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.52e-06	6.35e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	4.5e-06	6.32e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	4.15e-06	5.84e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.97e-06	5.59e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.91e-06	5.49e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—INS—Alzheimer's disease	3.9e-06	5.48e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.89e-06	5.47e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	3.88e-06	5.45e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.86e-06	5.43e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.83e-06	5.38e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.56e-06	5e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.42e-06	4.8e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.37e-06	4.73e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—INS—Alzheimer's disease	3.3e-06	4.64e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.2e-06	4.5e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.13e-06	4.39e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.99e-06	4.21e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.98e-06	4.19e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.95e-06	4.15e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.9e-06	4.07e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.65e-06	3.72e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.6e-06	3.65e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.55e-06	3.58e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	2.26e-06	3.18e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.23e-06	3.14e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.04e-06	2.87e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.57e-06	2.21e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.33e-06	1.87e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.03e-06	1.44e-05	CbGpPWpGaD
